New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Bristol-Myers Squibb Company
BMY
Shape
US Flag

NYSE

123B

Drug Manufacturers - General

Next Earning date - 24 Apr 2025

123B

Drug Manufacturers - General

Next Earning date - 24 Apr 2025

60.42USD

Shape0.34 ( 0.57%)
sun-fogPre-market 59.78$arrow-left-down-0.64 (-1.05%)
Market Closed (as of Mar 20, 20:00 EDT)
favorite-chart

Relative Strenght

85
favorite-chart

Volume Buzz

11%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

5%

Quote Panel

Shape
Updated March 21, 2025
1W 0.72 % 1M 4.39 % 3M 6.09 % 1Y 22.16 %

Key Metrics

Shape
  • Market Cap

    122.61B


  • Shares Outstanding

    2.03B


  • Share in Float

    2.03B


  • Dividende

    2.42


  • Earning Date

    24 Apr 2025


  • Price Target

    60.42


  • Average Volume

    10.98M


  • Beta

    0.436


  • Range

    39.35-63.33


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.bms.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

BMY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$46B

Shape270%

2025-Revenue

$6.74

Shape18883%

2025-EPS

$13B

Shape425%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Daiwa

upgrade

Previous: Not converted

2024-11-13

Now: Outperform

Bernstein

initialise

Previous: Not converted

2024-10-17

Now: Market Perform

Barclays

downgrade

Previous: Equal-Weight

2024-07-29

Now: Underweight

Deutsche Bank

initialise

Previous: Not converted

2024-01-30

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+5%

2.05
vs 1.96

Q2.23

arrow
arrow

-9%

1.75
vs 1.93

Q3.23

arrow
arrow

+1%

2
vs 1.99

Q4.23

arrow
arrow

-7%

1.7
vs 1.82

Q1.24

arrow
arrow

N/A

-4.40
vs 2.05

Q2.24

arrow
arrow

+18%

2.07
vs 1.75

Q3.24

arrow
arrow

-10%

1.8
vs 2

Q4.24

arrow
arrow

-2%

1.67
vs 1.7

Q1.25

arrow
arrow

+135%

1.52
vs -4.40

Q2.25

arrow
arrow

-18%

1.71
vs 2.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-3%

11.3B  vs 11.6B

Q2.23

arrow
arrow

-6%

11.2B  vs 11.9B

Q3.23

arrow
arrow

-2%

11B  vs 11.2B

Q4.23

arrow
arrow

+1%

11.5B  vs 11.4B

Q1.24

arrow
arrow

+5%

11.9B  vs 11.3B

Q2.24

arrow
arrow

+9%

12.2B  vs 11.2B

Q3.24

arrow
arrow

+8%

11.9B  vs 11B

Q4.24

arrow
arrow

+8%

12.3B  vs 11.5B

Q1.25

arrow
arrow

-10%

10.7B  vs 11.9B

Q2.25

arrow
arrow

-7%

11.3B  vs 12.2B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+7%

0.07
vs 0.07

Q2.23

arrow
arrow

+6%

0.06
vs 0.07

Q3.23

arrow
arrow

+7%

0.07
vs 0.06

Q4.23

arrow
arrow

+6%

0.06
vs 0.07

Q1.24

arrow
arrow

-72%

-0.72
vs 0.06

Q2.24

arrow
arrow

+10%

0.1
vs -0.72

Q3.24

arrow
arrow

+7%

0.07
vs 0.1

Q4.24

arrow
arrow

+0%

0
vs 0.07

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

2610

2.6K
vs 2.7K

-2%

Q2.23

arrow
arrow

2547

2.5K
vs 2.6K

-2%

Q3.23

arrow
arrow

2451

2.5K
vs 2.5K

-4%

Q4.23

arrow
arrow

2437

2.4K
vs 2.5K

-1%

Q1.24

arrow
arrow

2399

2.4K
vs 2.4K

-2%

Q2.24

arrow
arrow

2213

2.2K
vs 2.4K

-8%

Q3.24

arrow
arrow

2325

2.3K
vs 2.2K

5%

Q4.24

arrow
arrow

2502

2.5K
vs 2.3K

8%

Earnings Growth

Latest News